Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 1
1987 1
1991 2
1992 2
1999 3
2000 1
2001 2
2002 1
2003 3
2004 3
2005 2
2006 6
2007 3
2008 11
2009 7
2010 8
2011 8
2012 8
2013 9
2014 12
2015 10
2016 12
2017 12
2018 11
2019 10
2020 10
2021 9
2022 13
2023 12
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists.
Bendotti G, Montefusco L, Lunati ME, Usuelli V, Pastore I, Lazzaroni E, Assi E, Seelam AJ, El Essawy B, Jang J, Loretelli C, D'Addio F, Berra C, Ben Nasr M, Zuccotti G, Fiorina P. Bendotti G, et al. Among authors: lunati me. Pharmacol Res. 2022 Aug;182:106320. doi: 10.1016/j.phrs.2022.106320. Epub 2022 Jun 20. Pharmacol Res. 2022. PMID: 35738455 Review.
Anti-diabetic drugs and weight loss in patients with type 2 diabetes.
Lazzaroni E, Ben Nasr M, Loretelli C, Pastore I, Plebani L, Lunati ME, Vallone L, Bolla AM, Rossi A, Montefusco L, Ippolito E, Berra C, D'Addio F, Zuccotti GV, Fiorina P. Lazzaroni E, et al. Among authors: lunati me. Pharmacol Res. 2021 Sep;171:105782. doi: 10.1016/j.phrs.2021.105782. Epub 2021 Jul 22. Pharmacol Res. 2021. PMID: 34302978 Free article.
SGLT2-inhibitors are effective and safe in the elderly: The SOLD study.
Lunati ME, Cimino V, Gandolfi A, Trevisan M, Montefusco L, Pastore I, Pace C, Betella N, Favacchio G, Bulgheroni M, Bucciarelli L, Massari G, Mascardi C, Girelli A, Morpurgo PS, Folli F, Luzi L, Mirani M, Pintaudi B, Bertuzzi F, Berra C, Fiorina P. Lunati ME, et al. Pharmacol Res. 2022 Sep;183:106396. doi: 10.1016/j.phrs.2022.106396. Epub 2022 Aug 12. Pharmacol Res. 2022. PMID: 35970329
The anti-inflammatory and immunological properties of SGLT-2 inhibitors.
Bendotti G, Montefusco L, Pastore I, Lazzaroni E, Lunati ME, Fiorina P. Bendotti G, et al. Among authors: lunati me. J Endocrinol Invest. 2023 Dec;46(12):2445-2452. doi: 10.1007/s40618-023-02162-9. Epub 2023 Aug 3. J Endocrinol Invest. 2023. PMID: 37535237 Review.
Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule.
Ben Nasr M, Usuelli V, Dellepiane S, Seelam AJ, Fiorentino TV, D'Addio F, Fiorina E, Xu C, Xie Y, Balasubramanian HB, Castillo-Leon E, Loreggian L, Maestroni A, Assi E, Loretelli C, Abdelsalam A, El Essawy B, Uccella S, Pastore I, Lunati ME, Sabiu G, Petrazzuolo A, Ducci G, Sacco E, Centofanti L, Venturini M, Mazzucchelli S, Mattinzoli D, Ikehata M, Castellano G, Visner G, Kaifeng L, Lee KM, Wang Z, Corradi D, La Rosa S, Danese S, Yang J, Markmann JF, Zuccotti GV, Abdi R, Folli F, Fiorina P. Ben Nasr M, et al. Among authors: lunati me. Cell Metab. 2024 Jun 4;36(6):1302-1319.e12. doi: 10.1016/j.cmet.2024.05.001. Cell Metab. 2024. PMID: 38838642
eATP and autoimmune diabetes.
Loretelli C, Pastore I, Lunati ME, Abdelsalam A, Usuelli V, Assi E, Fiorina E, Loreggian L, Balasubramanian HB, Xie Y, Yang J, El Essawy B, Montefusco L, D'Addio F, Ben Nasr M, Fiorina P. Loretelli C, et al. Among authors: lunati me. Pharmacol Res. 2023 Apr;190:106709. doi: 10.1016/j.phrs.2023.106709. Epub 2023 Feb 25. Pharmacol Res. 2023. PMID: 36842542 Free article. Review.
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide.
Lunati ME, Cimino V, Bernasconi D, Gandolfi A, Morpurgo PS, Tinari C, Lazzaroni E, Baruffaldi L, Muratori M, Montefusco L, Pastore I, Rossi A, Franzetti IG, Muratori F, Manfrini R, Disoteo OE, Terranova R, Desenzani P, Girelli A, Ghelardi R, D'Addio F, Ben Nasr M, Berra C, Folli F, Bucciarelli L, Fiorina P. Lunati ME, et al. Pharmacol Res. 2024 Jan;199:107040. doi: 10.1016/j.phrs.2023.107040. Epub 2023 Dec 20. Pharmacol Res. 2024. PMID: 38128857 Free article.
Benefits and Hurdles of Pancreatic β-Cell Replacement.
Bolla AM, Montefusco L, Pastore I, Lunati ME, Ben Nasr M, Fiorina P. Bolla AM, et al. Among authors: lunati me. Stem Cells Transl Med. 2022 Oct 21;11(10):1029-1039. doi: 10.1093/stcltm/szac058. Stem Cells Transl Med. 2022. PMID: 36073717 Free PMC article. Review.
Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease.
Petrazzuolo A, Sabiu G, Assi E, Maestroni A, Pastore I, Lunati ME, Montefusco L, Loretelli C, Rossi G, Ben Nasr M, Usuelli V, Xie Y, Balasubramanian HB, Zocchi M, El Essawy B, Yang J, D'Addio F, Fiorina P. Petrazzuolo A, et al. Among authors: lunati me. Pharmacol Res. 2023 Apr;190:106710. doi: 10.1016/j.phrs.2023.106710. Epub 2023 Mar 4. Pharmacol Res. 2023. PMID: 36871895 Free article. Review.
175 results